Norgine B.V. enters into exclusive distribution agreement for the commercialisation of PLENVU® in China with Beijing Podconley…
Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and Beijing Podconley Pharmaceutical Technology & Development Co., Ltd. (Beijing Podconley), today announced an exclusive distribution agreement by which Beijing Podconley will commercialise Norgine's product PLENVU® in China. Norgine will receive upfront payments and undisclosed milestone payments, along with double-digit percentage royalties.
PLENVU® is a lower-volume (1L) polyethylene glycol (PEG) based bowel!-->…